Theratechnologies Stock Annual Yield

THTX Stock

USD 1.18 0.04 3.28%

Theratechnologies fundamentals help investors to digest information that contributes to Theratechnologies' financial success or failures. It also enables traders to predict the movement of Theratechnologies Stock. The fundamental analysis module provides a way to measure Theratechnologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Theratechnologies stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Theratechnologies Company Annual Yield Analysis

Theratechnologies' Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.

Yield

Income from Security

Current Share Price

More About Annual Yield | All Equity Analysis

Theratechnologies Annual Yield Driver Correlations

Understanding the fundamental principles of building solid financial models for Theratechnologies is extremely important. It helps to project a fair market value of Theratechnologies Stock properly, considering its historical fundamentals such as Annual Yield. Since Theratechnologies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Theratechnologies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Theratechnologies' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Short Term Investments	Current Deferred Revenue	Common Stock	Net Tangible Assets	Long Term Debt	Long Term Debt Total	Capital Surpluse	Property Plant Equipment	Net Invested Capital	Short Long Term Debt	Net Working Capital	Capital Stock	Deferred Long Term Liab
Total Assets		0.06	0.78	-0.57	0.94	0.77	0.84	0.94	0.28	0.84	0.51	-0.19	0.49	-0.51	0.9	0.83	0.72	0.59	0.8	0.84	0.35	0.51	0.27
Total Stockholder Equity	0.06		-0.46	0.57	0.11	-0.44	-0.44	-0.18	-0.46	0.32	0.26	-0.09	-0.6	0.76	-0.28	-0.39	-0.3	-0.68	0.5	0.25	0.64	-0.71	-0.85
Net Debt	0.78	-0.46		-0.74	0.78	0.85	0.92	0.86	0.48	0.53	0.37	-0.09	0.64	-0.81	0.85	0.86	0.79	0.91	0.4	0.64	-0.09	0.73	0.54
Retained Earnings	-0.57	0.57	-0.74		-0.4	-0.66	-0.74	-0.66	-0.41	-0.26	0.08	0.5	-0.66	0.72	-0.66	-0.69	-0.61	-0.75	-0.14	-0.28	0.14	-0.74	-0.67
Accounts Payable	0.94	0.11	0.78	-0.4		0.7	0.77	0.86	0.26	0.82	0.55	-0.03	0.36	-0.47	0.85	0.77	0.61	0.56	0.82	0.93	0.31	0.36	0.13
Net Receivables	0.77	-0.44	0.85	-0.66	0.7		0.95	0.9	0.29	0.54	0.42	-0.05	0.68	-0.79	0.86	0.92	0.85	0.87	0.41	0.45	0.08	0.8	0.66
Total Liab	0.84	-0.44	0.92	-0.74	0.77	0.95		0.96	0.43	0.56	0.38	-0.04	0.74	-0.86	0.95	0.98	0.77	0.9	0.51	0.6	0.06	0.82	0.65
Total Current Assets	0.94	-0.18	0.86	-0.66	0.86	0.9	0.96		0.32	0.69	0.52	-0.09	0.62	-0.68	0.94	0.94	0.76	0.77	0.69	0.71	0.26	0.7	0.46
Short Term Debt	0.28	-0.46	0.48	-0.41	0.26	0.29	0.43	0.32		0.08	0.05	-0.04	0.32	-0.5	0.33	0.34	0.29	0.34	0.0	0.38	-0.72	0.33	0.53
Intangible Assets	0.84	0.32	0.53	-0.26	0.82	0.54	0.56	0.69	0.08		0.42	-0.15	0.03	-0.22	0.63	0.56	0.56	0.26	0.82	0.78	0.49	0.11	-0.11
Short Term Investments	0.51	0.26	0.37	0.08	0.55	0.42	0.38	0.52	0.05	0.42		0.19	0.21	-0.01	0.35	0.33	0.5	0.25	0.49	0.46	0.29	0.18	-0.06
Current Deferred Revenue	-0.19	-0.09	-0.09	0.5	-0.03	-0.05	-0.04	-0.09	-0.04	-0.15	0.19		0.02	-0.1	0.03	0.03	-0.24	0.01	0.01	0.01	0.0	0.0	0.0
Common Stock	0.49	-0.6	0.64	-0.66	0.36	0.68	0.74	0.62	0.32	0.03	0.21	0.02		-0.77	0.73	0.72	0.58	0.8	0.04	0.17	-0.12	0.94	0.83
Net Tangible Assets	-0.51	0.76	-0.81	0.72	-0.47	-0.79	-0.86	-0.68	-0.5	-0.22	-0.01	-0.1	-0.77		-0.79	-0.85	-0.57	-0.91	-0.12	-0.32	0.26	-0.84	-0.81
Long Term Debt	0.9	-0.28	0.85	-0.66	0.85	0.86	0.95	0.94	0.33	0.63	0.35	0.03	0.73	-0.79		0.96	0.68	0.8	0.63	0.71	0.2	0.75	0.55
Long Term Debt Total	0.83	-0.39	0.86	-0.69	0.77	0.92	0.98	0.94	0.34	0.56	0.33	0.03	0.72	-0.85	0.96		0.69	0.87	0.56	0.6	0.16	0.79	0.6
Capital Surpluse	0.72	-0.3	0.79	-0.61	0.61	0.85	0.77	0.76	0.29	0.56	0.5	-0.24	0.58	-0.57	0.68	0.69		0.69	0.29	0.39	0.04	0.69	0.53
Property Plant Equipment	0.59	-0.68	0.91	-0.75	0.56	0.87	0.9	0.77	0.34	0.26	0.25	0.01	0.8	-0.91	0.8	0.87	0.69		0.16	0.35	-0.12	0.88	0.71
Net Invested Capital	0.8	0.5	0.4	-0.14	0.82	0.41	0.51	0.69	0.0	0.82	0.49	0.01	0.04	-0.12	0.63	0.56	0.29	0.16		0.85	0.65	0.04	-0.23
Short Long Term Debt	0.84	0.25	0.64	-0.28	0.93	0.45	0.6	0.71	0.38	0.78	0.46	0.01	0.17	-0.32	0.71	0.6	0.39	0.35	0.85		0.23	0.14	-0.05
Net Working Capital	0.35	0.64	-0.09	0.14	0.31	0.08	0.06	0.26	-0.72	0.49	0.29	0.0	-0.12	0.26	0.2	0.16	0.04	-0.12	0.65	0.23		-0.12	-0.47
Capital Stock	0.51	-0.71	0.73	-0.74	0.36	0.8	0.82	0.7	0.33	0.11	0.18	0.0	0.94	-0.84	0.75	0.79	0.69	0.88	0.04	0.14	-0.12		0.88
Deferred Long Term Liab	0.27	-0.85	0.54	-0.67	0.13	0.66	0.65	0.46	0.53	-0.11	-0.06	0.0	0.83	-0.81	0.55	0.6	0.53	0.71	-0.23	-0.05	-0.47	0.88

Click cells to compare fundamentals

Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.

Competition

Predict Theratechnologies

In accordance with the recently published financial statements, Theratechnologies has an Annual Yield of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Theratechnologies Current Valuation Drivers

We derive many important indicators used in calculating different scores of Theratechnologies from analyzing Theratechnologies' financial statements. These drivers represent accounts that assess Theratechnologies' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Theratechnologies' important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	709.8M	1.2B	831.6M	41.7M	37.6M	35.7M
Enterprise Value	752.5M	1.3B	874.4M	66.6M	59.9M	56.9M

Theratechnologies Fundamentals

	Return On Equity	-11.17
	Return On Asset	0.12
	Profit Margin	(0.04) %
	Operating Margin	0.27 %
	Current Valuation	73.93 M
	Shares Outstanding	45.98 M
	Shares Owned By Insiders	1.22 %
	Shares Owned By Institutions	51.56 %
	Number Of Shares Shorted	78.21 K
	Price To Book	20.13 X
	Price To Sales	0.66 X
	Revenue	81.76 M
	Gross Profit	56.22 M
	EBITDA	(10.31 M)
	Net Income	(23.96 M)
	Cash And Equivalents	36.46 M
	Cash Per Share	0.38 X
	Total Debt	58.97 M
	Debt To Equity	5.62 %
	Current Ratio	1.04 X
	Book Value Per Share	(0.43) X
	Cash Flow From Operations	(5.68 M)
	Short Ratio	2.39 X
	Earnings Per Share	(0.04) X
	Target Price	5.32
	Number Of Employees	103
	Beta	1.73
	Market Capitalization	55.72 M
	Total Asset	77.77 M
	Retained Earnings	(408.66 M)
	Working Capital	16 M
	Net Asset	77.77 M

About Theratechnologies Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Theratechnologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theratechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theratechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Theratechnologies Stock Analysis

When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC